Evaluation of vaccine-induced anti-lipopolysaccharide antibodies against clinically relevant Klebsiella pneumoniae strains to inform vaccine design
Researchers show that vaccine-induced antibodies targeting a surface sugar of Klebsiella pneumoniae can kill many clinically important strains, supporting simpler vaccine designs that may help combat neonatal sepsis and antibiotic resistance.